Abstract |
Dyspnea is a frequent, devastating, and poorly understood symptom of advanced lung cancer. In our cohort, among 519 patients who underwent a computed tomography scan for the diagnosis of lung cancer, 250 had a mean pulmonary artery diameter of >28 mm, indicating pulmonary hypertension (PH). In human lung cancer tissue, we consistently observed increased vascular remodeling and perivascular inflammatory cell accumulation (macrophages/lymphocytes). Vascular remodeling, PH, and perivascular inflammatory cell accumulation were mimicked in three mouse models of lung cancer (LLC1, KRasLA2 , and cRaf-BxB). In contrast, NOD.Cg-PrkdcscidIl2rgtm1Wjl/SzJ immunodeficient xenograft and dominant-negative IKK2 mutant triple transgenic (Sftpc-rtTA/Tet-O-Ikk2DN) mice did not develop PH. Coculturing human lung cancer cells with macrophages and lymphocytes strongly up-regulated cytokine release, provoking enhanced migration, apoptosis resistance, and phosphodiesterase 5 (PDE5)-mediated up-regulation of human lung vascular cells, which are typical features of PH. The PDE5 inhibitor sildenafil largely suppressed PH in the LLC1 model. We conclude that lung cancer-associated PH represents a distinct PH category; targeting inflammation in the microenvironment and PDE5 offers a potential therapeutic option.
|
Authors | Soni Savai Pullamsetti, Baktybek Kojonazarov, Samantha Storn, Henning Gall, Ylia Salazar, Janine Wolf, Andreas Weigert, Nefertiti El-Nikhely, Hossein Ardeschir Ghofrani, Gabriele A Krombach, Ludger Fink, Stefan Gattenlöhner, Ulf R Rapp, Ralph Theo Schermuly, Friedrich Grimminger, Werner Seeger, Rajkumar Savai |
Journal | Science translational medicine
(Sci Transl Med)
Vol. 9
Issue 416
(Nov 15 2017)
ISSN: 1946-6242 [Electronic] United States |
PMID | 29141888
(Publication Type: Journal Article)
|
Copyright | Copyright © 2017 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. |
Chemical References |
- NF-kappa B
- Cyclic Nucleotide Phosphodiesterases, Type 5
|
Topics |
- Animals
- Apoptosis
(physiology)
- Cell Line, Tumor
- Cells, Cultured
- Cyclic Nucleotide Phosphodiesterases, Type 5
(metabolism)
- Dendritic Cells
- Dyspnea
(immunology, physiopathology)
- Echocardiography
- Humans
- Hypertension, Pulmonary
(etiology, immunology, physiopathology)
- Immunohistochemistry
- In Vitro Techniques
- Inflammation
(immunology, physiopathology)
- Lung Neoplasms
(complications, immunology, physiopathology)
- Macrophages
(metabolism)
- Mice
- Mice, Inbred C57BL
- NF-kappa B
(metabolism)
- T-Lymphocytes
(metabolism)
|